Publication Date:
1994-05-27
Description:
Two major goals for the design of new catalysts are the facilitation of chemical transformations and control of product outcome. An antibody has been induced that efficiently catalyzes a cationic cyclization in which an acyclic olefinic sulfonate ester substrate is converted almost exclusively (98 percent) to a cyclic alcohol. The key to the catalysis of the reaction and the restriction of the product complexity is the use of antibody binding energy to rigidly enforce a concerted mechanism in accord with the design of the hapten. Thus, the ability to direct binding energy allows the experimenter to dictate a reaction mechanism which is an otherwise difficult task in chemistry. New catalysts for cationic cyclization may be of general use in the formation of carbon-carbon and carbon-heteroatom bonds leading to multi-ring molecules including steroids and heterocyclic compounds.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Li, T -- Janda, K D -- Ashley, J A -- Lerner, R A -- GM-43858/GM/NIGMS NIH HHS/ -- New York, N.Y. -- Science. 1994 May 27;264(5163):1289-93.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Scripps Research Institute, Department of Molecular Biology, La Jolla, CA 92037.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8191282" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Antibodies, Catalytic/*chemistry
;
Antibodies, Monoclonal/chemistry
;
Catalysis
;
Cations/*chemistry
;
Chromatography, Gas
;
Cyclization
;
Haptens
;
Kinetics
;
Mice
;
Organosilicon Compounds/*chemistry
;
Sulfanilic Acids/*chemistry
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
